JAZZ · Jazz Pharmaceuticals plc
$244.96
-0.89 (-0.36%)
At close · Aug 14
Market Cap
$15.90B
Shares
64.91M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Renee D. Gala | President, CEO and Director | $19,151,558 |
| Bruce Cozadd | Chairperson and former CEO | $18,834,836 |
| Robert Iannone | M.D., M.S.C.E Executive Vice President, Global Head of R&D | $8,661,758 |
| Philip Johnson | Executive Vice President and CFO | $7,544,473 |
| Neena M. Patil | Executive Vice President and Chief Legal Officer | $6,299,539 |
| Samantha Pearce | Executive Vice President, Chief Commercial Officer | $6,076,127 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Bruce Cozadd | Chairperson and CEO | $15,527,464 |
| Renee D. Gala | President, CEO and Director | $6,628,888 |
| Renee Gala | President and COO | $6,628,888 |
| Robert Iannone | M.D., M.S.C.E Executive Vice President, Global Head of R&D | $5,689,377 |
| Philip Johnson | Executive Vice President and CFO | $5,243,445 |
| Samantha Pearce | Executive Vice President, CCO | $4,464,254 |
| Neena M. Patil | Executive Vice President and Chief Legal Officer | $4,309,074 |
| Patricia Carr | Senior Vice President and CAO (Former Interim Principal Financial Officer) | $1,452,210 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Bruce Cozadd | Chairperson and CEO | $15,341,235 |
| Daniel Swisher | Former President and COO | $5,528,973 |
| Renee Gala | President and COO | $5,434,388 |
| Renee D. Gala | President, CEO and Director | $5,434,388 |
| Robert Iannone | M.D., M.S.C.E Executive Vice President, Global Head of R&D | $4,979,077 |
| Kim Sablich | Former Executive Vice President and General Manager, US | $4,165,304 |
| Neena M. Patil | Executive Vice President and Chief Legal Officer | $3,877,435 |
| Patricia Carr | Senior Vice President and CAO (Former Interim Principal Financial Officer) | $1,401,028 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Bruce Cozadd | Chairperson and CEO | $17,325,618 |
| Daniel Swisher | Former President and COO | $5,953,745 |
| Renee Gala | President and COO | $5,029,436 |
| Robert Iannone | M.D., M.S.C.E Executive Vice President, Global Head of R&D | $4,855,654 |
| Kim Sablich | Former Executive Vice President and General Manager, US | $4,303,200 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Bruce Cozadd | Chairperson and CEO | $15,679,311 |
| Daniel Swisher | Former President and COO | $5,403,892 |
| Renee Gala | President and COO | $4,605,224 |
| Chris Tovey | Executive Vice President and Chief Operating Officer and Managing Director, Europe and International | $4,168,001 |
| Robert Iannone | M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | $4,001,336 |
| Kim Sablich | Former Executive Vice President and General Manager, US | $3,947,509 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Bruce Cozadd | Chairperson and CEO | $12,573,300 |
| Kim Sablich | Executive Vice President and General Manager, US | $4,621,245 |
| Daniel Swisher | President, COO | $4,471,087 |
| Renee Gala | Executive Vice President and CFO | $4,123,400 |
| Robert Iannone | M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | $3,149,481 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Bruce Cozadd | Chairperson and CEO | $14,713,637 |
| Daniel Swisher | President RenéeGalá | $4,707,407 |
| Robert Iannone | M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | $3,693,560 |
| Matthew P. Young | Former Executive Vice President and CFO | $3,583,378 |
| Neena M. Patil | Senior Vice President and GC | $3,205,781 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Bruce Cozadd | Chairman and CEO | $11,443,133 |
| Daniel Swisher | President and COO RenéeGalá | $5,753,341 |
| Matthew P. Young | Former Executive Vice President and CFO | $3,356,337 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Bruce Cozadd | Chairman and CEO | $10,304,610 |
| Matthew P. Young | Former Executive Vice President and CFO | $3,292,653 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kenneth W. O'Keefe | director | Retired | 2025-10-28 |
| Dr. Ted Love | Class I director | Appointed | 2025-10-28 |
| Renee Gala | Class I director | Appointed | 2025-07-10 |
| Renee Gala | President & Chief Executive Officer | Appointed | 2025-07-10 |
| Catherine Sohn | director | Retired | 2024-05-31 |
| Patrick Kennedy | Class I director | Appointed | 2024-02-27 |
| Philip Johnson | Executive Vice President and Chief Financial Officer | Appointed | 2024-02-21 |
| Renée Galá | Executive Vice President and Chief Financial Officer | Resigned | 2023-09-12 |
| Renée Galá | President and Chief Operating Officer | Appointed | 2023-09-12 |
| Daniel Swisher, Jr. | President and Chief Operating Officer | Resigned | 2023-09-12 |
| Daniel Swisher, Jr. | President and Chief Operating Officer | Retired | 2023-09-12 |
Key facts
CIK
1232524
CUSIP
G50871105
13F (30d)
605 filings
582 filers
Visit website
Investor relations